Kenalog Dosing for a 17.1 kg Child
For a child weighing 17.1 kg, the appropriate dose of Kenalog (triamcinolone acetonide) depends entirely on the indication and route of administration, as systemic and intralesional dosing differ dramatically.
Systemic (Intramuscular) Dosing
If systemic corticosteroid therapy is indicated, the pediatric dose range is 0.11 to 1.6 mg/kg/day in 3-4 divided doses 1. For a 17.1 kg child:
- Minimum dose: 0.11 mg/kg/day = 1.88 mg/day
- Maximum dose: 1.6 mg/kg/day = 27.4 mg/day
For IM injection using Kenalog-40 (50 mg per 5 mL = 10 mg/mL concentration):
- A typical starting dose would be in the mid-range: approximately 10-15 mg as a single IM injection
- Volume to administer: 1.0-1.5 mL of the 50 mg/5 mL suspension
The FDA label emphasizes that dosage must be individualized based on the specific disease entity and patient response, with adjustments made in small decrements to find the lowest effective maintenance dose 1.
Intralesional Dosing (for Acne or Keloids)
If treating inflammatory nodular acne or keloids with intralesional injection, the dosing is completely different. For nodular acne, triamcinolone acetonide 10 mg/mL (or diluted to 5 or 3.3 mg/mL) is injected directly into lesions 2. The total dose depends on the number and size of lesions being treated, not body weight.
Critical Safety Considerations
- Benzyl alcohol warning: Kenalog-40 contains benzyl alcohol; use with extreme caution in young children due to risk of gasping syndrome 1
- Injection technique: For systemic IM use, inject deeply into the gluteal muscle to avoid subcutaneous fat atrophy 1
- Contraindications: Avoid at sites of active infection, in patients with systemic fungal infections or active tuberculosis 2
- Adverse effects: Monitor for hypothalamic-pituitary-adrenal axis suppression with repeated injections, local atrophy, pigmentary changes, and telangiectasias 2
Clinical Decision Algorithm
- Determine the indication: Is this for systemic inflammatory disease or local intralesional treatment?
- For systemic use: Start at 0.5-1.0 mg/kg (8.5-17 mg for this child), given as single IM dose
- For intralesional use: Dose based on lesion characteristics, not weight
- Assess response: Adjust dose downward to lowest effective maintenance level
- If long-term therapy needed: Taper gradually rather than stopping abruptly 1
Without knowing the specific indication, I cannot provide a single definitive dose, but the systemic IM starting range would be 10-17 mg (1.0-1.7 mL of the 50 mg/5 mL suspension) for this 17.1 kg child.